(1-(2-CYANOPROPAN-2-YL)-1H-PYRAZOL-4-YL)BORONIC ACID PINACOL ESTER – (2095779-29-4)

AB928, 2239273-34-6, Etrumadenant, AB-928, 3-(2-Amino-6-(1-((6-(2-hydroxypropan-2-yl)pyridin-2-yl)methyl)-1H-1, 2, 3-triazol-4-yl)pyrimidin-4-yl)-2-methylbenzonitrile, 3-[2-Amino-6-[1-[[6-(2-hydroxypropan-2-yl)pyridin-2-yl]methyl]triazol-4-yl]pyrimidin-4-yl]-2-methylbenzonitrile, Etrumadenant [USAN], W0ZE0NT8IF, UNII-W0ZE0NT8IF, ETRUMADENANT [INN], ETRUMADENANT [WHO-DD], 3-[2-Amino-6-[1-[[6-(1-hydroxy-1-methylethyl)-2-pyridinyl]methyl]-1H-1, 2, 3-triazol-4-yl]-4-pyrimidinyl]-2-methylbenzonitrile, 3-[2-amino-6-(1-{[6-(2-hydroxypropan-2-yl)pyridin-2-yl]methyl}-1H-1, 2, 3-triazol-4-yl)pyrimidin-4-yl]-2-methylbenzonitrile, 3-[2-azanyl-6-[1-[[6-(2-oxidanylpropan-2-yl)pyridin-2-yl]methyl]-1, 2, 3-triazol-4-yl]pyrimidin-4-yl]-2-methyl-benzenecarbonitrile, Benzonitrile, 3-[2-amino-6-[1-[[6-(1-hydroxy-1-methylethyl)-2-pyridinyl]methyl]-1H-1, 2, 3-triazol-4-yl]-4-pyrimidinyl]-2-methyl-, A2aR/A2bR antagonist-1, trumadenant, 3-(2-amino-6-(1-((6-(2-hydroxypropan-2-yl)pyridin-2-yl)methyl)triazol-4-yl)pyrimidin-4-yl)-2-methylbenzonitrile, Benzonitrile, 3-(2-amino-6-(1-((6-(1-hydroxy-1-methylethyl)-2-pyridinyl)methyl)-1H-1, 2, 3-triazol-4-yl)-4-pyrimidinyl)-2-methyl-, U30, MFCD32263040, Etrumadenant (USAN/INN), CHEMBL4740383, SCHEMBL20401465, A2AR/A2BR Antagonist AB928, C23H22N8O, GTPL11154, BCP33220, EX-A3172, AB 928, AB928?, BDBM50594625, Dual A2AR/A2BR Antagonist AB928, NSC823658, WHO 11620, ZB1610, AKOS037649091, AB928 AB 928, NSC-823658, AC-36346, BS-16547, HY-129393, CS-0105184, Adenosine A2A/A2B Receptor Antagonist AB928, D12369, D81385, EN300-7563176, Q66977586, 3-[2-amino-6-(1-{[6-(2-hydroxypropan-2-yl)pyridin-2-yl]methyl}-1, 2, 3-triazol-4-yl)pyrimidin-4-yl]-2-methylbenzonitrile